By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751



Company News
Rounding Up the Experts’ Thoughts on What's Next for Sarepta (SRPT)'s DMD Drug 4/27/2016 6:51:32 AM
FDA Panel’s 7-6 Vote Against Sarepta (SRPT)’s DMD Drug Underlines Battle Between Science and Patient Advocates 4/26/2016 6:20:20 AM
Sarepta (SRPT)’s Stock a Rollercoast Ride Prior to Today’s FDA Hearing 4/25/2016 7:01:00 AM
Sarepta (SRPT) Craters as the FDA Releases Documents Ahead of Monday’s DMD Drug Hearing 4/21/2016 7:05:20 AM
36 DMD Experts Send Letter to the FDA Urging Approval of Sarepta (SRPT)’s Drug 3/22/2016 6:20:28 AM
Sarepta (SRPT) Chairman and Two Directors Scoop Up $2.5 Million Worth of Shares 3/18/2016 6:28:10 AM
Sarepta (SRPT) Finally Gets Another Date with the FDA for DMD Drug 3/11/2016 6:27:23 AM
DMD Setback Prompts Sarepta (SRPT) to Shutter West Coast Location and Consolidate to Massachusetts, 30 Jobs Gone 3/9/2016 6:13:13 AM
Sarepta (SRPT) Announces Fourth Quarter And Full-Year 2015 Financial Results And Recent Corporate Developments 2/26/2016 8:17:50 AM
FDA Delays Decision on Sarepta (SRPT)'s Muscle-Wasting Disorder Drug 2/8/2016 7:19:13 AM